
NTES · Nasdaq
Consensus is Buy across 11 analysts, with a mean price target of $158 versus the latest supplied close of $130.60. The low and high targets are not reported, so target clustering and the width of the spread cannot be assessed. The evidence identifies neither the most bullish nor least bullish analyst and records no named rating or target revisions during the week; revision direction therefore cannot be established. The substantive disagreement behind any dispersion is also undocumented. FY2025 revenue and net income growth provide fundamental context, but the supplied material does not link that performance to individual analysts’ targets, forecasts, or valuation assumptions.